{"task_id": "a239f6b2d277b096", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 375/464)", "text": "s, leprosy,\nand peripheral neuropathies\nUlcers\n367\n\n--- Page 389 ---\nSPECIFIC ENTITIES (CONT\u2019D)\n\u0002\nCLINICAL FEATURES\na pure neuropathic ulcer is\npainless. There is diminished sensation in the\nlower extremity. Patients have warm extremities\nwith palpable pulses, as opposed to arterial ulcers\n\u0002\nTREATMENTS\ndiabetic patients require tight glu\ncose control. Treat infection with systemic antibio\ntics. Debridement of the ulcer, hyperbaric oxygen\ntherapy, and occlusive dressings are applied to\npromote wound healing. Immobilization and ortho\ntic devices are used to alleviate pressure on the\nwound. Amputation may be required in severe\ncases\nPYODERMA GANGRENOSUM\n\u0002\nPATHOPHYSIOLOGY\nchronic condition that involves\nneutrophilic destruction of tissue\n\u0002\nRISK\nFACTORS\napproximately 50% of patients\nhave an underlying systemic illness, including\nulcerative colitis (most common), Crohn disease,\nrheumatoid arthritis, lymphoproliferative disorder\n(lymphoma, leukemia, MDS), Beh\u00e7et syndrome,\nand active hepatitis\n\u0002\nCLINICAL\nFEATURES\ninitially, lesions appear as\nsmall, painful, erythematous papules that spread\nSPECIFIC ENTITIES (CONT\u2019D)\nconcentrically,\nevolving\ninto\npustules.\nTissue\nbreakdown and ulceration occur rapidly. Ulcers\nclassically have dusky red, violaceous, irregular\nborders with a purulent exudate and undermining.\nLesions are typically solitary, but may be multiple\nand coalesce into larger ulcers. It is typically found\non the lower extremity, but other common sites\ninclude the buttocks, abdomen, and face. ESR may\nbe elevated. Classically worsens with attempted\nbiopsy or debridement\n\u0002\nTREATMENTS\ntreat underlying causes where possi\nble. Immunosuppressive and immunomodulator\ntherapy such as high dose oral or IV glucocorticoids\n(prednisone 60 80 mg PO daily, pulse methylpredni\nsolone 1 g IV daily \u00033 day), cyclosporine, and TNF a\nblockade and IVIG 400 mg/kg IV daily \u00035 day or\n1 g/kg IV daily \u00032 day have been effective. Other\noptions include sulfasalazine, sulfones, minocycline,\nand dapsone. Topical and intralesional steroids and\ntacrolimus have also been used\nNEJM 2002 347:18\nMelanoma and Skin Tumors\nNEJM 2005 353:21; NEJM 2004 351:10;\nNEJM 2001 344:13\nDIFFERENTIAL DIAGNOSIS OF PIGMENTED LESIONS\nBENIGN\nnevus (congenital, acquired), freckle,\nseborrheic keratosis, cafe au Lait\nPRE MALIGNANT\ndysplastic nevi syndrome\nMALIGNANT\nmelanoma (superficial spreading,\nnodular, lentigo maligna, acral lentiginous), pig\nmented basal cell carcinoma\nPATHOPHYSIOLOGY\nRISK FACTORS OF MELANOMA\n\u0002\nGENETICS\nfair skin, red/blonde hair, blue eyes,\nfamily history\n\u0002\nNEVI\nnumber of common/atypical nevi (marker\nof sun exposure), familial dysplastic nevus syn\ndrome, previous melanoma\n\u0002\nEXPOSURE\nintermittent intense sun exposure,\nphototherapy, immunosuppression\nHISTOLOGIC TYPE\n\u0002\nSUPERFICIAL SPREADING (70%)\nfifth decade of life,\nboth sexes, initial radial growth, common on back,\nposterior legs of women\n\u0002\nNODULAR (15%)\ngrows rapidly vertically. More\ncommon in men\n\u0002\nLENTIGO MALIGNA (10 15%)\nsun damaged skin,\nolder patients, 5 20 year radial growth phase\nPATHOPHYSIOLOGY (CONT\u2019D)\n\u0002\nACRAL LENTIGINOUS\nmost common melanoma in\npigmented patients. Affects palms, soles, and nails\nCLINICAL FEATURES\nDISTRIBUTION\nmore common on the trunk in men\nand extremities in women. Typically occur in relatively\nnon pigmented areas in non whites. Unusual primary\nsites for melanoma include CNS, eyes, mucosa (respira\ntory, GI, GU), palate, gingival, vulva and anus\nSYMPTOMS\n\u0002\nLOCOREGIONAL\nskin\nlesion\n(see\nJAMA\nseries\nbelow)\n\u0002\nMETASTATIC\ndepending on location (lung, GI tract,\nliver, brain, subcutaneous, skin, bone, heart)\n\u0002\nPARANEOPLASTIC\nvitiligo, melanosis syndrome (slate\ngray skin discoloration), dermatomyositis, gyneco\nmastia, Cushing\u2019s, hypercalcemia, neurological\nRATIONAL CLINICAL EXAMINATION SERIES: DOES\nTHIS PATIENT HAVE A MOLE OR A MELANOMA?\nCHECKLIST wABCDw\nAsymmetry, Border irregu\nlarity, Color variegation, Diameter >6 mm (sens\n92 100%, spc 98% depending on how many criteria\n368\nMelanoma and Skin Tumors", "text_length": 4003, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 375/464)", "type": "chunk", "chunk_index": 374, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.767018", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.767762", "status": "complete"